(HART) IQ Healthy Hearts - Ratings and Ratios
Healthcare Stocks, Pharmaceuticals, Medical Devices, Biotechnology
Description: HART IQ Healthy Hearts
The IQ Healthy Hearts ETF (NYSE ARCA: HART) is a passively managed exchange-traded fund designed to replicate the performance of an index developed by IndexIQ LLC, with Candriam, an affiliate of IndexIQ, serving as the index consultant. The fund tracks an index that includes equities of various market capitalizations—large-, mid-, and small-cap companies—trading in both U.S. and international markets, excluding certain emerging markets such as China, Egypt, India, Kuwait, Pakistan, Qatar, Saudi Arabia, and the United Arab Emirates. As a non-diversified fund, it may concentrate its investments in a smaller number of securities, which can lead to higher volatility compared to diversified funds.
Ticker Symbol: HART | Exchange: NYSE ARCA | Type: ETF | Country Origin: USA | ETF Category: Health
Based on the provided data, HART currently trades at $31.05, with a 20-day average volume of 1200 shares. Its short-term moving averages (SMA 20: $31.85, SMA 50: $32.02) suggest recent price stability, while the 200-day SMA ($31.71) indicates a slightly lower long-term trend. The Average True Range (ATR) of 0.25 reflects low volatility, suggesting minimal price fluctuations. The funds assets under management (AUM) stand at $9.32 million, a relatively small size for an ETF, which may impact liquidity.
3-Month Forecast:
-
Additional Sources for HART ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
HART ETF Overview
Market Cap in USD | 9m |
Category | Health |
TER | 0.45% |
IPO / Inception | 2021-01-14 |
HART ETF Ratings
Growth Rating | 27.9 |
Fundamental | - |
Dividend Rating | 50.5 |
Rel. Strength | -13.8 |
Analysts | - |
Fair Price Momentum | 28.06 USD |
Fair Price DCF | - |
HART Dividends
Dividend Yield 12m | 1.52% |
Yield on Cost 5y | 1.98% |
Annual Growth 5y | 6.91% |
Payout Consistency | 100.0% |
Payout Ratio | % |
HART Growth Ratios
Growth Correlation 3m | 66.4% |
Growth Correlation 12m | -61.4% |
Growth Correlation 5y | 80.2% |
CAGR 5y | 5.68% |
CAGR/Max DD 5y | 0.33 |
Sharpe Ratio 12m | 0.87 |
Alpha | -11.65 |
Beta | 0.573 |
Volatility | 12.87% |
Current Volume | 0.3k |
Average Volume 20d | 0.2k |
Stop Loss | 29.2 (-3.4%) |
As of July 12, 2025, the stock is trading at USD 30.22 with a total of 298 shares traded.
Over the past week, the price has changed by +0.56%, over one month by -0.25%, over three months by +3.27% and over the past year by -2.14%.
Neither. Based on ValueRay´s Analyses, IQ Healthy Hearts is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 27.85 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HART is around 28.06 USD . This means that HART is currently overvalued and has a potential downside of -7.15%.
IQ Healthy Hearts has no consensus analysts rating.
According to our own proprietary Forecast Model, HART IQ Healthy Hearts will be worth about 31.7 in July 2026. The stock is currently trading at 30.22. This means that the stock has a potential upside of +5%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 31.7 | 5% |